Literature DB >> 26686585

In vitro and in vivo osteogenic activity of the novel vancomycin-loaded bone-like hydroxyapatite/poly(amino acid) scaffold.

Zhidong Cao1, Dianming Jiang2, Ling Yan3, Jun Wu3.   

Abstract

BACKGROUND: Antibiotic-loaded carriers were developed because of their ability to fill cavities and deliver antibiotics locally following implantation. However, the most commonly used antibiotic carrier, polymethyl methacrylate, has many shortcomings, such as heat production, non-bioresorbable and lack of bone regeneration or conduction. Bone-like hydroxyapatite/poly(amino acid) scaffolds have been shown to have controllable biodegradability, nontoxicity, some osteogenic and osteoconductive properties, which has great potential as a carrier for local delivery of antibiotics. Vancomycin-loaded bone-like hydroxyapatite/poly(amino acid) was successfully fabricated by a homogeneous method using a diffusion control system. In this study, bone regeneration using this scaffold was observed both in vitro and in vivo.
METHODS: In vitro tests, MG63 cells were incubated with the vancomycin-loaded scaffold to observe its effects on the activation of osteoblasts. In vivo tests, the scaffolds were implanted into rabbit models of chronic osteomyelitis, including regular and methicillin-resistant Staphylococcus aureus. The effects were evaluated by gross observation, X-ray and histological observation.
RESULTS: After incubating with the scaffold, MG63 cells exhibited good proliferative activity, and increased calcium and alkaline phosphatase synthesis compared with blank control group. In vivo tests, the experimental group showed increased bone growth in infectious bone defects compared with the control groups, regardless of the type of Staphylococcus aureus.
CONCLUSION: Vancomycin-loaded bone-like hydroxyapatite/poly(amino acid) scaffold has good potential for the repair of infectious bone defects because of its ability to deliver antibiotics and promote bone regeneration.
© The Author(s) 2015.

Entities:  

Keywords:  Chronic osteomyelitis; bone-like hydroxyapatite/poly(amino acid); drug release; osteogenesis; scaffold

Mesh:

Substances:

Year:  2015        PMID: 26686585     DOI: 10.1177/0885328215623735

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  4 in total

Review 1.  Biodegradable Bone Implants as a New Hope to Reduce Device-Associated Infections-A Systematic Review.

Authors:  José C C Paiva; Luís Oliveira; Maria Fátima Vaz; Sofia Costa-de-Oliveira
Journal:  Bioengineering (Basel)       Date:  2022-08-22

2.  An effective treatment of experimental osteomyelitis using the antimicrobial titanium/silver-containing nHP66 (nano-hydroxyapatite/polyamide-66) nanoscaffold biomaterials.

Authors:  Minpeng Lu; Junyi Liao; Jing Dong; Jun Wu; Hao Qiu; Xin Zhou; Jidong Li; Dianming Jiang; Tong-Chuan He; Zhengxue Quan
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

3.  In vitro and in vivo drug release and antibacterial properties of the novel vancomycin-loaded bone-like hydroxyapatite/poly amino acid scaffold.

Authors:  Zhidong Cao; Dianming Jiang; Ling Yan; Jun Wu
Journal:  Int J Nanomedicine       Date:  2017-03-08

Review 4.  Recent advances in the local antibiotics delivery systems for management of osteomyelitis.

Authors:  Reem Khaled Wassif; Maha Elkayal; Rehab Nabil Shamma; Seham A Elkheshen
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.